Zhao Zhang

Overview:

Dr. Zhang is Assistant Professor of Pharmacology and Cancer Biology. He earned his Ph.D. from University of Massachusetts Medical School in 2014. Skipped PostDoc training, Dr. Zhang established his own research group in  2014 at Carnegie Institution for Science, Department of Embryology, which is affiliated with Johns Hopkins University. In 2019, he was recruited to Duke University as the very first scholar from the Duke Science and Technology program. His lab studies transposons and circular DNA during development and tumorigenesis. His research has been recognized by multiple awards, including NIH Director's Early Independence Award, the Larry Sandler Award from the Genetics Society of America, and Pew Biomedical Scholar.

Positions:

Assistant Professor of Pharmacology and Cancer Biology

Pharmacology & Cancer Biology
School of Medicine

Assistant Professor of Cell Biology

Cell Biology
School of Medicine

Member of the Duke Human Vaccine Institute

Duke Human Vaccine Institute
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Affiliate of the Duke Regeneration Center

Regeneration Next Initiative
School of Medicine

Education:

Ph.D. 2013

University of Massachusetts Medical School

Grants:

Training Program in Developmental and Stem Cell Biology

Administered By
Basic Science Departments
Awarded By
National Institutes of Health
Role
Mentor
Start Date
End Date

Somatic transposition-mediated genome variegation during development, disease and aging conditions

Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Regulating and harnessing immunity with junk DNA

Administered By
Pharmacology & Cancer Biology
Awarded By
Pew Charitable Trusts
Role
Principal Investigator
Start Date
End Date

Regulation, function, and impact of developmental retrotransposon activation

Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Regulation, function, and impact of developmental retrotransposon activation

Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Publications:

Retrotransposon activation during Drosophila metamorphosis conditions adult antiviral responses.

Retrotransposons are one type of mobile genetic element that abundantly reside in the genomes of nearly all animals. Their uncontrolled activation is linked to sterility, cancer and other pathologies, thereby being largely considered detrimental. Here we report that, within a specific time window of development, retrotransposon activation can license the host's immune system for future antiviral responses. We found that the mdg4 (also known as Gypsy) retrotransposon selectively becomes active during metamorphosis at the Drosophila pupal stage. At this stage, mdg4 activation educates the host's innate immune system by inducing the systemic antiviral function of the nuclear factor-κB protein Relish in a dSTING-dependent manner. Consequently, adult flies with mdg4, Relish or dSTING silenced at the pupal stage are unable to clear exogenous viruses and succumb to viral infection. Altogether, our data reveal that hosts can establish a protective antiviral response that endows a long-term benefit in pathogen warfare due to the developmental activation of mobile genetic elements.
Authors
Wang, L; Tracy, L; Su, W; Yang, F; Feng, Y; Silverman, N; Zhang, ZZZ
MLA Citation
Wang, Lu, et al. “Retrotransposon activation during Drosophila metamorphosis conditions adult antiviral responses.Nat Genet, vol. 54, no. 12, Dec. 2022, pp. 1933–45. Pubmed, doi:10.1038/s41588-022-01214-9.
URI
https://scholars.duke.edu/individual/pub1556486
PMID
36396707
Source
pubmed
Published In
Nat Genet
Volume
54
Published Date
Start Page
1933
End Page
1945
DOI
10.1038/s41588-022-01214-9

Retrotransposons hijack alt-EJ DNA repair process for mobilization and eccDNA biogenesis

Authors
Yang, F; Su, W; Chung, O; Tracy, L; Wang, L; Ramsden, D; Zhang, ZZZ
MLA Citation
Yang, Fu, et al. “Retrotransposons hijack alt-EJ DNA repair process for mobilization and eccDNA biogenesis.” BioRxiv, 2022. Epmc, doi:10.1101/2022.09.25.509424.
URI
https://scholars.duke.edu/individual/pub1550842
Source
epmc
Published Date
DOI
10.1101/2022.09.25.509424

Developmental retrotransposon activation primes host immunity for future viral-clearance

Transposons are thought to be largely suppressed under physiological conditions, ensuring that their mobilization is a rare event. By tracking mobilization, we show that during metamorphosis at the Drosophila pupal stage, the Gypsy retrotransposon selectively mobilizes in regenerating tissues. In the newly formed tissues, this wave of Gypsy activation primes the host’s innate immune system by inducing the production of a nti m icrobial p eptides (AMPs). Moreover, early immune-priming functions of Gypsy are essential for combating viral invasion in adult flies: flies with Gypsy being silenced at the pupal stage are unable to clear viruses and succumb to viral infection. Our data reveal that regulated activation of transposons during animal developmental endows a long-term benefit in pathogen warfare.
Authors
Wang, L; Tracy, L; Zhang, ZZZ
MLA Citation
Wang, Lu, et al. Developmental retrotransposon activation primes host immunity for future viral-clearance. 2020. Epmc, doi:10.1101/2020.08.23.263293.
URI
https://scholars.duke.edu/individual/pub1456205
Source
epmc
Published Date
DOI
10.1101/2020.08.23.263293

Research Areas:

Muser Mentor